z-logo
open-access-imgOpen Access
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
Author(s) -
Stefanie Reis,
MariaInti Metzendorf,
Rebecca Kuehn,
Maria Popp,
Ildikó Gágyor,
Peter Kranke,
Patrick Meybohm,
Nicole Skoetz,
Stephanie Weibel
Publication year - 2022
Publication title -
cochrane library
Language(s) - English
Resource type - Journals
eISSN - 1465-184X
pISSN - 1464-780X
DOI - 10.1002/14651858.cd015395.pub2
Subject(s) - medicine , ritonavir , randomized controlled trial , medline , placebo , health care , covid-19 , scopus , intensive care medicine , alternative medicine , disease , family medicine , infectious disease (medical specialty) , human immunodeficiency virus (hiv) , viral load , pathology , antiretroviral therapy , political science , law , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom